Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00278447 · ClinicalTrials.gov registry record · Phase 3
Addiction Health Evaluation And Disease Management (AHEAD) Study
A Phase 3 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 569
- Enrollment target
NCT00278447 is a Phase 3 study that has completed, run by Boston Medical Center. The registered enrollment target is 569 participants.
The verdict
NCT00278447, a Phase 3 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 569 participants
- Enrollment target
Study Summary
The objective of this study is to test whether a chronic disease management (CDM) program for substance abusers in primary care leads to improved alcohol and drug-related outcomes (such as reduced consumption and health problems) and health care utilization patterns.
Interventions
- BEHAVIORAL Standard care
- BEHAVIORAL Chronic Disease Management for substance abuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00278447
The ClinicalTrials.gov registry entry for NCT00278447 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 569 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard care is the first listed.
NCT00278447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00278447 about?
NCT00278447 is a clinical study titled "Addiction Health Evaluation And Disease Management (AHEAD) Study". The objective of this study is to test whether a chronic disease management (CDM) program for substance abusers in primary care leads to improved alcohol and drug-related outcomes (such as reduced consumption and health problems) and health care utilization patterns.
What is the current status of trial NCT00278447?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 569 participants. The study started on 2006-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00278447?
The interventions under investigation include: Standard care (BEHAVIORAL), Chronic Disease Management for substance abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT00278447?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.